Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
Clinical trial NCT01691508 · COMPLETED
Trial details
- NCT number
- NCT01691508
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-12-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.